Melphalan and Whole-Body Hyperthermia in Treating Patients With Advanced Melanoma
Completed · Phase 2
Conditions studied: Melanoma (Skin)
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Hyperthermia therapy kills tumor cells by heating them to several degrees above body temperature. Combining hyperthermia with chemotherapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of melphalan and whole-body hyperthermia in treating patients with advanced melanoma.
Key facts
- Study ID
- NCT00002973
- Run by
- University of Wisconsin, Madison
- People needed
- 34
- Starts
- 1995-12-01
- Expected to finish
- 2000-12-01
- Last updated by the study team
- 2015-10-02
Who can join
Age: 16 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Wisconsin Comprehensive Cancer Center — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.